Physician profile
Bernice W Aidoo
NPI 1750540837
$889.42
in general payments reported to CMS, 2019-2025
13 companies · $60.22 in 2025
The $60.22 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $62.78 · 2021: $146 · 2022: $137 · 2023: $193 · 2024: $189 · 2025: $60.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $268.58 | 2019-2024 | Xarelto |
| Pfizer INC. | $116.09 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $87.03 | 2023-2025 | Zerbaxa, Dificid, Recarbrio |
| Smith+Nephew, INC. | $78.06 | 2021-2025 | Collagenase Santyl |
| Novo Nordisk INC | $70.66 | 2022-2024 | Rybelsus, Ozempic |
| Ucb, INC. | $58.12 | 2021-2024 | Briviact |
| Fisher & Paykel Healthcare INC | $49.41 | 2024 | Fisher & Paykel Healthcare |
| Gilead Sciences, INC. | $37.94 | 2022-2023 | Veklury |
| Mylan Specialty L.P. | $37.77 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $33.53 | 2023 | Lokelma |
| E.R. Squibb & Sons, L.L.C. | $19.47 | 2019 | |
| Vapotherm INC | $18.53 | 2024 | Vapotherm |
| Melinta Therapeutics, LLC | $14.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernice Aidoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.